COVID virus

U of M Team Examines the Protective Role of PDE5 Inhibitors During COVID-19 Infection

July 16, 2020

Researchers are examining the protective role that common PDE5 inhibitor medications might play during COVID-19 infection. If proven, these medications could potentially lead to milder symptoms, fewer hospitalizations, and quicker recoveries in COVID-19 patients with pre-existing heart and lung diseases.

Other News

SeroNet COVID-19 Vaccine Response Study screenshot
The University of Minnesota is leading a research study that aims to better understand the immune system’s response to COVID-19 vaccines.…
Drs. Prasad and Natarajan
With the news of a COVID-19 outbreak in India and the World Health Organization urging countries to address global inequalities in health,…
medical reserve
As the fight against COVID-19 becomes a charge to quickly vaccinate Minnesotans—especially the most vulnerable—there remain key…